148 related articles for article (PubMed ID: 36420099)
21. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy with a micro-multileaf collimator for brain metastasis in the primary motor cortex.
Matsuda R; Hasegawa M; Tamamoto T; Ochi T; Miyasaka T; Inooka N; Hontsu S; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Nakase H
J Radiat Res; 2022 Jan; 63(1):63-70. PubMed ID: 34927204
[TBL] [Abstract][Full Text] [Related]
22. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
23. Single dose versus fractionated stereotactic radiotherapy for meningiomas.
Lo SS; Cho KH; Hall WA; Kossow RJ; Hernandez WL; McCollow KK; Gerbi BJ; Higgins PD; Lee CK; Dusenbery KE
Can J Neurol Sci; 2002 Aug; 29(3):240-8. PubMed ID: 12195613
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
[TBL] [Abstract][Full Text] [Related]
25. Fractionated stereotactic radiotherapy for local control of resected brain metastases.
Traylor JI; Habib A; Patel R; Muir M; Gadot R; Briere T; Yeboa DN; Li J; Rao G
J Neurooncol; 2019 Sep; 144(2):343-350. PubMed ID: 31313060
[TBL] [Abstract][Full Text] [Related]
26. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
27. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
[TBL] [Abstract][Full Text] [Related]
28. Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases.
Johannwerner L; Werner EM; Janssen S; Yu NY; Rades D
Anticancer Res; 2023 Jun; 43(6):2757-2762. PubMed ID: 37247897
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
Cho KH; Hall WA; Lo SS; Dusenbery KE
Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
[TBL] [Abstract][Full Text] [Related]
30. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
31. Single-centre experience of stereotactic radiosurgery and fractionated stereotactic radiotherapy for prolactinomas with the linear accelerator.
Wilson PJ; Williams JR; Smee RI
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):371-8. PubMed ID: 25410143
[TBL] [Abstract][Full Text] [Related]
32. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
[TBL] [Abstract][Full Text] [Related]
35. Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis.
Palmer JD; Greenspoon J; Brown PD; Johnson DR; Roberge D
Neurooncol Pract; 2020 Jun; 7(3):263-267. PubMed ID: 32537175
[TBL] [Abstract][Full Text] [Related]
36. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases.
Ahmed KA; Freilich JM; Abuodeh Y; Figura N; Patel N; Sarangkasiri S; Chinnaiyan P; Yu HH; Etame AB; Rao NG
J Neurooncol; 2014 May; 118(1):179-86. PubMed ID: 24604750
[TBL] [Abstract][Full Text] [Related]
37. Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma.
Kaul D; Budach V; Wurm R; Gruen A; Graaf L; Habbel P; Badakhshi H
Radiat Oncol; 2014 Mar; 9():78. PubMed ID: 24650090
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
[TBL] [Abstract][Full Text] [Related]
39. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
40. Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
Musunuru HB; Witt JS; Yadav P; Francis DM; Kuczmarska-Haas A; Labby ZE; Bassetti MF; Howard SP; Baschnagel AM
J Neurooncol; 2019 Nov; 145(2):385-390. PubMed ID: 31606876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
